Aortic Stenosis Treatment Market
Aortic Stenosis Treatment Market Study by Transcatheter Aortic Valve Replacement, Surgical Aortic Valve Replacement, Balloon Valvuloplasty, Beta Blockers, and Cardiac Glycosides from 2024 to 2034
Analysis of Aortic Stenosis Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Aortic Stenosis Treatment Market Outlook (2024 to 2034)
Worldwide revenue from aortic stenosis treatment solutions is expected to reach US$ 7.57 billion in 2024, as revealed in Fact.MR’s newly published market report. The global aortic stenosis treatment market size has been forecasted to expand at a CAGR of 9.7% and climb to a value of US$ 19.09 billion by 2034-end.
The geriatric population in the world is now more than ever before. These elderly people are more prone to developing aortic stenosis, which is driving demand for effective treatment options. Availability of improved, more effective, and patient-centric treatment is contributing to market growth. Aortic stenosis is considered the third most found cardiac disease, after coronary heart disease and hypertension. Growing expenditure for developing new treatment methods against valvular heart diseases is contributing to market prospects.
Developing more effective bio-prosthetic heart valves is one of the key innovations in the market. Currently, available surgical options available for severe aortic stenosis are tissue valves or heart valves, which are developed from animal tissues. Further, mechanical valves need medications for blood thinning, which can cause risks associated with bleeding and durability issues.
Newly developed valves are specifically designed from biomaterials mimicking natural human valves closely. These help in minimizing risks associated with aortic stenosis.
- Revenue from aortic stenosis treatment solutions in hospitals is evaluated to increase at a CAGR of 9.9% and reach US$ 11.68 billion by the end of 2034.
- Demand for aortic stenosis treatment solutions in India is analyzed to increase at a CAGR of 14.5% from 2024 to 2034.
- The market in Japan is projected to expand at a 3.7% CAGR through 2034.
- North America is projected to capture 44.3% of the global aortic stenosis treatment market share by 2034.
- Sales of aortic stenosis treatment devices in South Korea are forecasted to rise at a CAGR of 10.5% from 2024 to 2034.
| Report Attribute | Detail |
|---|---|
| Aortic Stenosis Treatment Market Size (2024E) | US$ 7.57 Billion |
| Forecasted Market Value (2034F) | US$ 19.09 Billion |
| Global Market Growth Rate (2024 to 2034) | 9.7% CAGR |
| Market Share of Transcatheter Aortic Valve Replacement Segment (TAVR) (2034F) | 67.9% |
| Western Europe Market Share (2034F) | 14.9% |
| Canada Market Growth Rate (2024 to 2034) | 13.7% CAGR |
| Key Companies Profiled | Braile Biomédica; Edwards Lifesciences Corporation; Thubrikar Aortic Valve; Medtronic Plc; AstraZeneca Plc; Micro Interventional Devices, Inc.; Abbott Laboratories; Meril Life Sciences Pvt. Ltd.; Boston Scientific Corporation; JenaValve Technology, Inc.; LivaNova PLC; CryoLife, Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving Development of Effective Aortic Stenosis Treatment Solutions?
“Rising Population of Geriatric People and Technological Advancements in Healthcare”
Aortic stenosis is a prevalent condition among older adults. As the global population ages, the incidence of aortic stenosis rises, driving the need for effective treatments. Continuous advancements in medical technology, including transcatheter aortic valve replacement, minimally invasive procedures, and other treatment solutions, ensure the availability of effective options for managing aortic stenosis. All of these factors are driving aortic stenosis treatment market growth.
Which Key Issues are Encountered by Market Players?
“High Cost of Treatment and Lack of Approved Drug Therapies”
One of the prominent challenges against market growth is a lack of drug therapies approved by governing authorities, which is creating issues related to their authenticity. In addition, currently, valve replacement is used as a popular treatment option by more healthcare providers. Moreover, certain risks are associated with the preoperative procedures, which is also somewhat restraining the aortic stenosis treatment market size. The high costs of aortic stenosis treatment are also limiting opportunities for market players, particularly in developing countries.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Market Trends Should Start-ups Capitalize On?
“Investments in R&D Activities for Exploring Need for New Treatment Options”
New companies are investing significantly in the development of innovative therapies for use as an effective treatment against aortic stenosis. Moreover, they need to focus on expanding their presence across developing countries to generate immense profit.
Country-wise Insights
North America is evaluated to account for a share of 44.3% of the global market by the end of 2034, as mentioned in the study newly published by Fact.MR, a market research and competitive intelligence provider. The prominence of the region in the global market is attributed to the growing cases of aortic stenosis among more individuals. In addition, the presence of well-established healthcare infrastructure is also generating lucrative opportunities for market players in the region.
Why is the United States a Key Market for Aortic Stenosis Treatment Solutions?
“Presence of Well-established Healthcare System”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 2.49 Billion |
| Growth Rate (2024 to 2034) | 11% CAGR |
| Projected Value (2034F) | US$ 7.05 Billion |
The United States is analyzed to hold 83.5% share of the market in North America by 2034. The country is securing a significant share of regional market revenue owing to the presence of a well-developed healthcare system. In addition, increased investment in medical R&D activities is also contributing to revenue streams for market players.
What is the Future Scenario of Aortic Stenosis Treatment in India?
“Rising Cases of Valve Diseases Driving Demand for Effective Treatment Solutions”
| Attribute | India |
|---|---|
| Market Value (2024E) | US$ 451.7 Million |
| Growth Rate (2024 to 2034) | 14.5% CAGR |
| Projected Value (2034F) | US$ 1.75 Billion |
India is evaluated to occupy a share of 67.9% of the South Asia & Pacific market by 2034-end. Market growth is attributed to the rising cases of valve diseases. Moreover, unhealthy lifestyles along with constant improvements in the healthcare facilities are also positively influencing aortic stenosis treatment market trends.
What is Driving Opportunities for Aortic Stenosis Treatment Providers in Japan?
“Growing Population of Geriatric People More Prone to Aortic Stenosis”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 332.8 Million |
| Growth Rate (2024 to 2034) | 3.7% CAGR |
| Projected Value (2034F) | US$ 477.9 Million |
Japan is evaluated to hold 17.3% share of the market in East Asia by the end of 2034. The increasing geriatric population in the country is opening doors for providers of aortic stenosis treatment solutions. These geriatric people are more prone to aortic stenosis due to their comparatively weaker immune systems, which is generating demand for effective healthcare facilities. In addition, more people are willing to spend more on medical facilities to lead a healthy life.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Increasing use of TAVR solutions for inoperable and high-risk patients is attributed to their assistance in shorter hospital stays, reduced invasiveness, and quicker recovery time.
Which Treatment Type Accounts for a Leading Market Share?
“Preference for TAVR Solutions for Their Minimally Invasive Nature”
| Attribute | Transcatheter Aortic Valve Replacement (TAVR) |
|---|---|
| Segment Value (2024E) | US$ 4.94 Billion |
| Growth Rate (2024 to 2034) | 10.1% CAGR |
| Projected Value (2034F) | US$ 12.96 Billion |
TAVR is forecasted to capture a share of 67.9% of global market revenue by 2034-end. This is a minimally invasive treatment procedure used for treating aortic stenosis. With constant advancements in procedural techniques and medical technology, there is increased demand for TAVR as a preferred treatment option instead of conventional open-heart surgery.
More healthcare providers are giving preference to transcatheter aortic valve replacements among larger patient pools, especially low-risk patients, which is further generating opportunities for market players. Shorter hospital stays, reduced invasiveness, and quicker recovery times are some of the benefits of using the TAVR treatment option.
Which End User is Generating Relatively Higher Revenue Streams?
“High Demand for Aortic Stenosis Treatment in Hospitals Backed by More Effective Services”
| Attribute | Hospitals |
|---|---|
| Market Value (2024E) | US$ 4.56 Billion |
| Growth Rate (2024 to 2034) | 9.9% CAGR |
| Projected Value (2034F) | US$ 11.68 Billion |
Hospitals are projected to contribute 61.2% share of the global market by the end of 2034. More patients with aortic stenosis are opting for hospitals due to the availability of more proficient healthcare providers. Surgery is the permanent treatment available against aortic stenosis, which is pushing more patients to visit hospitals to get access to effective treatment. In addition, facilities for regular checkups and medications for patients against aortic stenosis and minimizing complications are also driving market growth.
Competitive Landscape
Key players in the aortic stenosis treatment market are coming up with more advanced approved drugs and treatment solutions to ensure effective healthcare facilities.
For instance :
- Abbott is one of the prominent companies actively involved in discovering, manufacturing, and selling a diversified and broad line of healthcare services and products in the United States. In January 2023, the company announced approvals of its system, Navitor, by the FDA. This new generation TAVI (transcatheter aortic valve implantation) system is used prominently in treating people facing issues related to severe aortic stenosis who are at higher or extreme risks of open-heart surgery.
- Medtronic is one of the popular companies involved in developing diagnostic and therapeutic medical products. In September 2022, the company announced the expansion of its United States market with the release of the Evolut FX TAVR system. It adds features to the existing Evolut platform for enhancing predictable valve deployment and ease-of-use services.
Fact.MR provides detailed information about the price points of key players in the aortic stenosis treatment market positioned across the world, sales growth, production capacity, and speculative technological expansion, in this newly published market report.
Segmentation of Aortic Stenosis Treatment Market Research
-
By Treatment Type :
- Transcatheter Aortic Valve Replacement (TAVR)
- Surgical Aortic Valve Replacement (SAVR)
- Balloon Valvuloplasty
- Diuretics
- Angiotensin Converting Enzyme Inhibitors
- Beta Blockers
- Cardiac Glycosides
-
By End User :
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Cardiac Catheterization Labs
-
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- Middle East and Africa
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Treatment Type 6.2. End User 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Treatment Type 7.1. Transcatheter Aortic Valve Replacement (TAVR) 7.2. Surgical Aortic Valve Replacement (SAVR) 7.3. Balloon Valvuloplasty 7.4. Diuretics 7.5. Angiotensin Converting Enzyme Inhibitors 7.6. Beta Blockers 7.7. Cardiac Glycosides 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User 8.1. Hospitals 8.2. Ambulatory Surgical Centers (ASCs) 8.3. Cardiac Catheterization Labs 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. East Asia 9.6. South Asia & Pacific 9.7. Middle East & Africa 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Sales Forecast 2024 to 2034 by Treatment Type, End User, and Region for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Braile Biomédica 19.2. Edwards Lifesciences Corporation 19.3. Thubrikar Aortic Valve 19.4. Medtronic Plc 19.5. AstraZeneca Plc 19.6. Micro Interventional Devices, Inc. 19.7. Abbott Laboratories 19.8. Meril Life Sciences Pvt. Ltd. 19.9. Boston Scientific Corporation 19.10. JenaValve End User, Inc. 19.11. LivaNova PLC 19.12. CryoLife, Inc. 20. Assumptions and Acronyms Used 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Treatment Type, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Treatment Type, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Treatment Type, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 10: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 11: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 12: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Treatment Type, 2019 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Treatment Type, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Treatment Type, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 19: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 20: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 21: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 22: Latin America Market Value (US$ Mn) Analysis, by Treatment Type, 2019 to 2023
Table 23: Latin America Market Value (US$ Mn) Analysis, by Treatment Type, 2024 to 2034
Table 24: Latin America Market Value (US$ Mn) Opportunity Analysis, by Treatment Type, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 28: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 29: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 30: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 31: Western Europe Market Value (US$ Mn) Analysis, by Treatment Type, 2019 to 2023
Table 32: Western Europe Market Value (US$ Mn) Analysis, by Treatment Type, 2024 to 2034
Table 33: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Treatment Type, 2024 to 2034
Table 34: Western Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 35: Western Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 36: Western Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 37: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Eastern Europe Market Value (US$ Mn) Analysis, by Treatment Type, 2019 to 2023
Table 41: Eastern Europe Market Value (US$ Mn) Analysis, by Treatment Type, 2024 to 2034
Table 42: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Treatment Type, 2024 to 2034
Table 43: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 44: Eastern Europe Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 45: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 46: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 47: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 48: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Treatment Type, 2019 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Treatment Type, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Treatment Type, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 55: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 56: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 57: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 58: South Asia & Pacific Market Value (US$ Mn) Analysis, by Treatment Type, 2019 to 2023
Table 59: South Asia & Pacific Market Value (US$ Mn) Analysis, by Treatment Type, 2024 to 2034
Table 60: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Treatment Type, 2024 to 2034
Table 61: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 62: South Asia & Pacific Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 63: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
Table 64: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 65: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 66: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 67: MEA Market Value (US$ Mn) Analysis, by Treatment Type, 2019 to 2023
Table 68: MEA Market Value (US$ Mn) Analysis, by Treatment Type, 2024 to 2034
Table 69: MEA Market Value (US$ Mn) Opportunity Analysis, by Treatment Type, 2024 to 2034
Table 70: MEA Market Value (US$ Mn) Analysis, by End User, 2019 to 2023
Table 71: MEA Market Value (US$ Mn) Analysis, by End User, 2024 to 2034
Table 72: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Treatment Type, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Treatment Type, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Treatment Type, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by End User, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by End User, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 14: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 15: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 16: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 17: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 18: North America Market Share Analysis by Country, 2024 & 2034
Figure 19: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 20: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 21: North America Market Share and BPS Analysis by Treatment Type, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projections by Treatment Type, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Treatment Type, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 27: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 28: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 29: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 30: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 31: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 32: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 33: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 34: Latin America Market Share and BPS Analysis by Treatment Type, 2024 & 2034
Figure 35: Latin America Market Y-o-Y Growth Projections by Treatment Type, 2024 to 2034
Figure 36: Latin America Market Attractiveness Analysis by Treatment Type, 2024 to 2034
Figure 37: Latin America Market Share and BPS Analysis by End User, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by End User, 2024 to 2034
Figure 40: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 41: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 42: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 43: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 44: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 45: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 46: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 47: Western Europe Market Share and BPS Analysis by Treatment Type, 2024 & 2034
Figure 48: Western Europe Market Y-o-Y Growth Projections by Treatment Type, 2024 to 2034
Figure 49: Western Europe Market Attractiveness Analysis by Treatment Type, 2024 to 2034
Figure 50: Western Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 51: Western Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 52: Western Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 53: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 54: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 55: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 56: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 57: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 58: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 59: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 60: Eastern Europe Market Share and BPS Analysis by Treatment Type, 2024 & 2034
Figure 61: Eastern Europe Market Y-o-Y Growth Projections by Treatment Type, 2024 to 2034
Figure 62: Eastern Europe Market Attractiveness Analysis by Treatment Type, 2024 to 2034
Figure 63: Eastern Europe Market Share and BPS Analysis by End User, 2024 & 2034
Figure 64: Eastern Europe Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 65: Eastern Europe Market Attractiveness Analysis by End User, 2024 to 2034
Figure 66: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 67: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 68: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 69: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 70: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 71: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 72: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: East Asia Market Share and BPS Analysis by Treatment Type, 2024 & 2034
Figure 74: East Asia Market Y-o-Y Growth Projections by Treatment Type, 2024 to 2034
Figure 75: East Asia Market Attractiveness Analysis by Treatment Type, 2024 to 2034
Figure 76: East Asia Market Share and BPS Analysis by End User, 2024 & 2034
Figure 77: East Asia Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 78: East Asia Market Attractiveness Analysis by End User, 2024 to 2034
Figure 79: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 80: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 81: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 82: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 83: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 84: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 85: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 86: South Asia & Pacific Market Share and BPS Analysis by Treatment Type, 2024 & 2034
Figure 87: South Asia & Pacific Market Y-o-Y Growth Projections by Treatment Type, 2024 to 2034
Figure 88: South Asia & Pacific Market Attractiveness Analysis by Treatment Type, 2024 to 2034
Figure 89: South Asia & Pacific Market Share and BPS Analysis by End User, 2024 & 2034
Figure 90: South Asia & Pacific Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 91: South Asia & Pacific Market Attractiveness Analysis by End User, 2024 to 2034
Figure 92: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 93: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 94: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 95: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 96: MEA Market Share Analysis by Country, 2024 & 2034
Figure 97: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 98: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 99: MEA Market Share and BPS Analysis by Treatment Type, 2024 & 2034
Figure 100: MEA Market Y-o-Y Growth Projections by Treatment Type, 2024 to 2034
Figure 101: MEA Market Attractiveness Analysis by Treatment Type, 2024 to 2034
Figure 102: MEA Market Share and BPS Analysis by End User, 2024 & 2034
Figure 103: MEA Market Y-o-Y Growth Projections by End User, 2024 to 2034
Figure 104: MEA Market Attractiveness Analysis by End User, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the market size for aortic stenosis treatment in 2024?
The global aortic stenosis treatment market is valued at US$ 7.57 billion in 2024.
What is the demand outlook for aortic stenosis treatment by 2034?
Global revenue from aortic stenosis treatment is evaluated to reach US$ 19.09 billion by 2034.
At what rate is the global market projected to expand?
The market for aortic stenosis treatment is forecasted to expand at 9.7% CAGR through 2034.
How much share of the global market is North America analyzed to hold?
North America is analyzed to account for 44.3% share of global market revenue by 2034.
At what rate is the demand for aortic stenosis treatment solutions approximated to increase in South Korea?
The market in South Korea is projected to advance at 10.5% CAGR through 2034.
What is the contribution of hospitals to global market revenue?
Hospitals are evaluated to capture a share of 61.2% of the global market by 2034.
Who are the leading market players in this business space?
Some of the key market players are Medtronic Plc, Abbott Laboratories, LivaNova PLC, CryoLife, Inc., and Braile Biomédica.
What is gold treatment for aortic stenosis?
Treatment for severe aortic stenosis includes valve replacement accomplished either through a less invasive process or open-heart surgery.
Aortic Stenosis Treatment Market